The plakin family: Versatile organizers of cytoskeletal architecture

Current Opinion in Genetics and Development

Volumn 7, Issue 3, 1997, Pages 392-397

  Ruhrberg, Christiana ^a   Watt, Fiona M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BULLOUS PEMPHIGOID ANTIGEN 1; DESMOPLAKIN; ENVOPLAKIN; MESSENGER RNA; PLECTIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; CYTOARCHITECTURE; CYTOSKELETON; INTERMEDIATE FILAMENT; PEMPHIGOID; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FAMILY; PROTEIN LOCALIZATION; REVIEW; SKIN DISEASE; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION;

EID: 0030795164     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80154-2     Document Type: Article

References (48)

1. Bornslaeger EA, Stappenbeck TS, Kowalczyk AP, Palka HL, Green KJ: Molecular genetic analysis of desmosomal proteins. In Molecular Biology of Desmosomes and Hemidesmosomes. Edited by Collins JE, Garrod DR. RG Landes Company; 1994:35-52.
2. Foisner R, Wiche G: Intermediate filament-associated proteins. Curr Opin Cell Biol 1991, 3:75-81.
3. Stanley JR: Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid bullous diseases due to defective epidermal cell adhesion. Adv Immunol 1993, 53:291-325.
4. Simon M, Green H: Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell 1984, 36:827-834.
5. Uitto J, Pulkkinen L, Smith FJH, McClean WHI: Plectin and human genetic disorders of the skin and muscle. Exp Dermatol 1996, 5:237-246. A comprehensive review of plectin mutations in hereditary human disease.
6. Ruhrberg C, Hajibagheri MA, Simon M, Dooley TP, Watt FM: Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol 1996, 134:715-729. This paper describes the sequence of envoplakin and its subcellular distribution in keratinocytes. The work establishes that desmosome components are incorporated into the cornified envelope, thus providing an explanation of how the cornified envelope is linked to keratin filaments and desmosomes.
7. Foisner R, Bohn W, Mannweiler K, Wiche G: Distribution and ultrastructure of plectin arrays in subclones of rat glioma C6 cells differing in intermediate filament protein (vimentin) expression. J Struct Biol 1995, 115:304-317. See annotation [17••].
8. Seifert GJ, Lawson D, Wiche G: Immunolocalization of the intermediate filament-associated protein plectin at focal contacts and actin stress fibers. Eur J Cell Biol 1992, 59:138-147.
9. Green KJ, Parry DA, Steinert PM, Virata ML, Wagner RM, Angst BD, Nilles LA: Structure of the human desmoplakins. Implications for function in the desmosomal plaque [published erratum in J Biol Chem 1990, 265:11406-11407]. J Biol Chem 1990, 265:2603-2612.
10. Virata ML, Wagner RM, Parry DA, Green KJ : Molecular structure of the human desmoplakin I and II amino terminus. Proc Natl Acad Sci USA 1992, 89:544-548.
11. Wiche G, Becker B, Luber K, Weitzer G, Castanon MJ, Hauptmann R, Stratowa C, Stewart M: Cloning and sequencing of rat plectin indicates a 466 kD polypeptide chain with a three-domain structure based on a central alpha-helical coiled coil. J Cell Biol 1991, 114:83-99.
12. Sawamura D, Li K, Chu ML, Uitto J: Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains. J Biol Chem 1991, 266:17784-11790.
13. Green KJ, Virata ML, Elgart GW, Stanley JR, Parry DA: Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments, Int J Biol Macromol 1992, 14:145-153.
14. O'Keefe EJ, Erickson HP, Bennett V: Desmoplakin I and desmoplakin II. Purification and characterization. J Biol Chem 1989, 264:8310-8318.
15. Foisner R, Wiche G: Structure and hydrodynamic properties of plectin molecules. J Mol Biol 1987, 198:515-531.
16. Foisner R, Leichtfried FE, Herrmann H, Small JV, Lawson DI, Wiche G: Cytoskeleton-associated plectin: in situ localization, in vitro reconstitution, and binding to immobilized intermediate filament proteins. J Cell Biol 1988, 106:723-733.
17. Svitkina TM, Verkhovsky AB, Borisy GG: Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J Cell Biol 1996, 135:991-1007. References [7•,17••] contain beautiful electron micrographs of plectin cross-bridges. These results provide new insights into the role of plectin complexes in crosslinking cytoskeletal elements.
18. Liu CG, Maercker C, Castanon MJ, Hauptmann R, Wiche G: Human plectin: organization of the gene, sequence analysis, and chromosome localization (8q24). Proc Natl Acad Sci USA 1996, 93:4278-4283. See annotation [19••].
19. McLean WH, Pulkkinen L, Smith FJ, Rugg EL, Lane EB, Bullrich F, Burgeson RE, Amano S, Hudson DL, Owaribe K et al.: Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 1996, 10:1724-1735. References [18•,19••] describe the sequence of human plectin and its genomic organization; [18•] also extends the known sequence of rat plectin at the amino terminus, whereas [19••] describes, for the first time, human plectin mutations.
20. Tamai K, Sawamura D, Do HC, Tamai Y, Li K, Uitto J: The human 230 kD bullous pemphigoid antigen gene (BPAG1). Exon-intron organization and identification of regulatory tissue specific elements in the promoter region. J Clin Invest 1993, 92:814-822.
21. Angst BD, Nilles LA, Green KJ: Desmoplakin II expression is not restricted to stratified epithelia. J Cell Sci 1990, 97:247-257.
22. -/- mice. Using gene targeting technology, the authors are able to show that a member of the plakin family is absolutely required for tissue stability.
23. Brown A, Bernier G, Mathieu M, Rossant J, Kothary R: The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet 1995, 10:301-306.
24. Brown A, Dalpe G, Mathieu M, Kothary R: Cloning and characterization of the neural isoforms of human dystonin. Genomics 1995, 29:777-780.
25. -/- mice and illustrates the functional significance of alternative splicing of a member of the plakin family.
26. Hopkinson SB, Jones JC: Identification of a second protein product of the gene encoding a human epidermal autoantigen. Biochem J 1994, 300:851-857.
27. Sanchez-Aparicio P, De Velasco M, Niessen CM, Borradori L, Kuikman L, Hulsman EHM, Faessler R, Owaribe K, Sonnenberg A: The subcellular distribution of the high molecular mass protein, HD-1, is determined by the cytoplasmic domain of integrin β4 subunit J Cell Sci 1997, 110:169-178.
28. Skalli O, Jones JC, Gagescu R, Goldman RD: IFAP 300 is common to desmosomes and hemidesmosomes and is a possible linker of intermediate filaments to these junctions. J Cell Biol 1994, 125:159-170.
29. Herrmann H, Wiche G: Plectin and IFAP-300K are homologous proteins binding to microtubule-associated proteins 1 and 2 and to the 240 kilodalton subunit of spectrin. J Biol Chem 1987, 262:1320-1325.
30. Stappenbeck TS, Green KJ: The desmoplakin carboxyl terminus coaligns with and specifically disrupts intermediate filament networks when expressed in cultured cells. J Cell Biol 1992, 116:1197-1209.
31. Stappenbeck TS, Bornslaeger EA, Corcoran CM, Luu HH, Virata ML, Green KJ : Functional analysis of desmoplakin domains: specification of the interaction with keratin versus vimentin intermediate filament networks. J Cell Biol 1993, 123:691-705.
32. Kouklis PD, Hutton E, Fuchs E: Making a connection: direct binding between keratin intermediate filaments and desmosomal proteins. J Cell Biol 1994, 127:1049-1060.
33. Wiche G, Gromov D, Donovan A, Castanon MJ, Fuchs E: Expression of plectin mutant cDNA in cultured cells indicates a role of COOH-terminal domain in intermediate filament association. J Cell Biol 1993, 121:607-619.
34. Nikolic B, MacNulty E, Mir B, Wiche G: Basic amino acid residue cluster within nuclear targeting sequence motif is essential for cytoplasmic plectin-vimentin network junctions. J Cell Biol 1996, 134:1455-1467.
35. Bornslaeger EA, Corcoran CM, Stappenbeck TS, Green KJ: Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J Cell Biol 1996, 134:985-1001. This paper includes the remarkable observation that the expression of the amino terminus of desmoplakin results in the formation of cell junctions containing both desmosome and adherens junction components.
36. Steinert PM, Marekov LN: Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified envelope. J Biol Chem 1997, 272:2021-2030. This paper describes the sequencing of peptides released from purified cornified envelopes and provides direct evidence that envoplakin and desmoplakin are incorporated into envelopes in vivo.
37. Chavanas S, Pulkkinen L, Gache Y, Smith FJD, McLean WHI, Uitto J, Ortonne JP, Meneguzzi G: A homozygous nonsense mutation in the pled gene in patients with epidermolysis-bullosa simplex with muscular-dystrophy. J Clin Invest 1996, 98:2196-2200.
38. Gache Y, Chavanas S, Lacour JP, Wiche G, Owaribe K, Meneguzzi G, Ortonne JP: Defective expression of plectin/hd1 in epidermolysis-bullosa simplex with muscular-dystrophy. J Clin Invest 1996, 97:2289-2298.
39. Pulkkinen L, Smith FJD, Shimizu H, Murata S, Yaoita H, Hachisuka H, Nishikawa T, McLean WHI, Uitto J: Homozygous deletion mutations in the plectin gene (pled) in patients with epidermolysis-bullosa simplex associated with late-onset muscular-dystrophy. Hum Mol Genet 1996, 5:1539-1546.
40. Smith FJD, Eady RAJ, Leigh IM, McMillan JR, Rugg EL, Kelsell DP, Bryant SP, Spurr NK, Geddes JF, Kirtschig G et al.: Plectin deficiency results in muscular-dystrophy with epidermolysis-bullosa. Nat Genet 1996, 13:450-457.
41. Oursler JR, Labib RS, Ariss-Abdo L, Burke T, O'Keefe EJ, Anhalt GJ: Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 1992, 89:1775-1782.
42. Hashimoto T, Amagai M, Watanabe K, Chorzelski TP, Bhogal BS, Black MM, Stevens HP, Boorsma DM, Korman NJ, Gamou S et al.: Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995, 104:829-834.
43. Ruhrberg C, Williamson JA, Sheer D, Watt FM: Chromosomal localisation of the human envoplakin gene (EVPL) to the region of the Tylosis Oesophageal Cancer Gene (TOCG) on 17q25. Genomics 1996, 37:381-385.
44. Fujiwara S, Kohno K, Iwamatsu A, Naito I, Shinkai H: Identification of a 450 kDa human epidermal autoantigen as a new member of the plectin family. J Invest Dermatol 1996, 106:1125-1130.
45. Fujiwara S, Kohno K, Iwamatsu A, Naito I, Shinkai H: A 450 kDa human epidermal autoantigen. Connect Tissue 1997, in press.
46. Tamai K, Li K, Silos S, Rudnicka L, Hashimoto T, Nishikawa T, Uitto J: Interferon-gamma-mediated inactivation of transcription of the 230 kDa bullous pemphigoid antigen gene (BPAG1) provides novel insight into keratinocyte differentiation. J Biol Chem 1995, 270:392-396.
47. Stappenbeck TS, Lamb JA, Corcoran CM, Green KJ: Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate filament networks. J Biol Chem 1994, 269:29351-29354.
48. Foisner R, Malecz N, Dressel N, Stadler C, Wiche G: M-phase-specific phosphorylation and structural rearrangement of the cytoplasmic cross-linking protein plectin involve p34cdc2 kinase. Mol Biol Cell 1996, 7:273-288.